Video: LAPAROSCOPIC CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAPERITONEAL CHEMOPERFUSION IN GASTRIC CANCER
Peritoneal metastasis from gastric cancer represents advanced disease with poor prognosis. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemoperfusion (HIPEC) has shown survival benefit in some malignancies, but its role in the treatment of gastric cancer peritoneal metastasis is not completely elucidated. CRS-HIPEC at the time of potentially curative gastrectomy seems to add survival benefit, especially in patients with positive cytology.
Laparoscopic CRS-HIPEC (L-CRS-HIPEC) has been investigated as a less invasive treatment option in patients with gastric cancer with limited peritoneal carcinomatosis or positive peritoneal cytology.
We aim to present a case of a 61-year-old woman with a gastric adenocarcinoma from the lesser curvature, with a positive cytology for tumor cells. The patient initiated chemotherapy with FOLFOX and the re-staging CT scan showed no sign of distant metastasis.